Institution
University of Seville
Education•Seville, Andalucía, Spain•
About: University of Seville is a education organization based out in Seville, Andalucía, Spain. It is known for research contribution in the topics: Population & Context (language use). The organization has 20098 authors who have published 47317 publications receiving 947007 citations. The organization is also known as: Universidad de Sevilla.
Topics: Population, Context (language use), Model predictive control, Nonlinear system, Control theory
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The positive outcomes obtained with different programs of pharmaceutical care are making a beneficial change in patients' health but still more research projects should be conducted to support this change.
Abstract: Since the concept of Pharmaceutical Care was introduced from United States about twenty years ago, this initiative has become a dominant form of practice for thousands of pharmacists around the world. Currently, pharmaceutical care is understood as the pharmacists' compromise to obtain the maximum benefit from the pharmacological treatments of the patients, being therefore responsible of monitoring their pharmacotherapy. As the profession has moved from a product orientation (dispensing medications) to a patient focus, clinical training requirements have expanded. This is a slow but ongoing process, which started from a philosophical point of view, in order to transform the concept of Pharmacy from commodity-based, mercantile operations into a clinical profession in the community pharmacies. Since its introduction, there has been an ample debate on the definition of pharmaceutical care due to differences in Pharmacy systems and in health care structure among the different countries. Moreover, several implementation barriers exist, which are attributable to problems in education, skills, resources and environment. Indeed, an awareness of the problem resulting from the use of medicines exists and numerous studies reflect that drug use control is necessary since there is an important relationship between morbidity / mortality and pharmacotherapy. Thus, it is possible to evaluate the benefits of pharmaceutical care on patients' health and ultimately on society. Many studies have been conducted, which show that the provision of pharmaceutical care has its value in common pathologies such as diabetes, hypertension, asthma, hyperlipidemia, chronic pain, rheumatic diseases or psychiatric disorders, as well as in polymedicated patients. A large amount of data is currently being published in biomedical journals, in an effort to establish the clinical, economic and humanistic viability of pharmaceutical care. Thus, the aim of this review is to study the evolution of this practice from its beginning until nowadays. Furthermore, we have analyzed a number of implementation programs performed in countries of Europe, the United States and Latin America, focusing on clinical, economical and humanistic outcomes, and also, on the current concept of drug therapy problems (DTP) considered as failures in drug therapy. We conclude that the positive outcomes obtained with different programs of pharmaceutical care are making a beneficial change in patients' health but still more research projects should be conducted to support this change.
176 citations
••
TL;DR: This study strongly suggests that the VPP reflects an early visual stage of face processing in the fusiform gyrus that is strictly stimulus-related and independent of familiarity, and shows that source localization algorithms may give reliable solutions on single subject averages for early visual components despite high inter-subject variability of the surface characteristics of ERPs.
176 citations
••
TL;DR: Using composts in agriculture to minimize organic wastes and to reduce the addition of fertilizers and fungicides in crop production is highly effective, and Rhizoctonia damping-off in cucumber plants can be reduced by using composts and/or the biological control agent T. asperellum strain T-34.
175 citations
••
TL;DR: In this paper, a CuO/CeO2 catalyst was examined with respect to its performance for preferential oxidation of CO in H2-rich streams and the results were explained on the basis of characterization by operando-DRIFTS and complemented with the analysis of redox properties by electron paramagnetic resonance (EPR) and X-ray photoelectron spectra (XPS).
Abstract: A CuO/CeO2 catalyst is examined with respect to its performance for preferential oxidation of CO in H2-rich streams. Catalytic activity results are explained on the basis of characterization by operando-DRIFTS and complemented with the analysis of redox properties by electron paramagnetic resonance (EPR) and X-ray photoelectron spectra (XPS). General catalytic activity features are accounted for by comparative analysis of the activities for individual CO and H2 oxidation, for which similar CuO and CeO2 interfacial active sites appear to be involved. An interesting particularity is related to observation of a low temperature hydrogen oxidation process in which CO apparently acts as gaseous promoter. A deactivation process taking place rapidly under the reactant stream is evidenced and attributed to accumulation of hydroxyls on the interfacial active sites and/or to copper sintering in the course of the run.
175 citations
••
TL;DR: Results indicate that vaccination with outer membrane vesicles may be a viable strategy for preventing A. baumannii infection.
175 citations
Authors
Showing all 20465 results
Name | H-index | Papers | Citations |
---|---|---|---|
Russel J. Reiter | 169 | 1646 | 121010 |
Aaron Dominguez | 147 | 1968 | 113224 |
Jose M. Ordovas | 123 | 1024 | 70978 |
Detlef Lohse | 104 | 1075 | 42787 |
Miroslav Krstic | 95 | 955 | 42886 |
María Vallet-Regí | 95 | 711 | 41641 |
John S. Sperry | 93 | 160 | 35602 |
Jose Rodriguez | 93 | 803 | 58176 |
Shun-ichi Amari | 90 | 495 | 40383 |
Michael Ortiz | 87 | 467 | 31582 |
Bruce J. Paster | 84 | 261 | 28661 |
Floyd E. Dewhirst | 81 | 229 | 42613 |
Joan Montaner | 80 | 489 | 22413 |
Francisco B. Ortega | 79 | 503 | 26069 |
Luis Paz-Ares | 77 | 592 | 31496 |